ERBB2 and neoplasm: In contrast, at the anti-EGFR antibody-treated tumor site (iii) in Fig. 6(b), the distinct bands at 1285 and 1648 cm−1 corresponding to the anti-HER2-FAF610-SERSRITC dots were only observed in the Raman spectra.